Macro Dragon: Welcome to WK # 42 - 3Q Earnings, Brexit, EU Council, NZ Elections, US Stimulus?

Macro 2 minutes to read

Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: Welcome to WK # 42 - 3Q Earnings, Brexit, EU Council, NZ Elections, US Stimulus?

 

Top of Mind…

  • Happy Monday Folks & Welcome to WK # 42…

  • Hope everyone had an abundant filled wkd

  • What kind of week are you trying to have up ahead?

  • Focus: Again very much still US politics to dominate until the election results are clear, especially given Trump’s Covid-19 & 180 flip (as we postulated) on a stimulus bill. Note the US is out for a long wkd & back in fully on Tues. Still the nomination of ACB to fill RBG seat on the Supreme court should kick off today with a vote expected before Nov.

  • Anything is still possible in regards to potential presidential debates: Dragon’s ring-side coaching to one of the teams is to bin one of the debates, among other advice going forward

  • Whilst the situation is still dynamic, it looks like for Oct 15, Biden is hosting a townhall – given the WH turned down a virtual debate.

  • Whether we will see one more Trump vs. Biden, remains to be seen – it looks like the doctors have cleared Trump to be able to leave the WH, saying he is no longer considered a transmission risk, yet not confirmation about him testing negative for Covid-19 – likely because he still has Covid. Worth noting so far, he seems to be holding up well.

  • It is worth noting that developments on the side of Brexit continue with Oct 15 deadline, yet are not gaining the headlines & focus they normally would.

  • We also have election in NZ, where the incumbent is expected to easily secure the next term. Plus coming Fri & WKD will see IMF meetings whose conclusion will likely be – we need more fiscal, risk to recovery if fiscal stalls, global healthcare framework is needed, etc.

  • Markets: Really all about the Stimulus, the move on Fri was very much on talks that trump wanted a fiscal deal. It’s unclear how much of an effect the kick-off of 3Q earnings will have.

  • Earnings: A number of banks will be reporting their earnings this wk including JPM, Citi, BoA, GS, MS, WTC, UBS & MS. A few other big names are Blackrock, United Health, Honeywell & chipmaker TSM.

  • There are a number of interesting charts to look into, including: lower lows in USDCNH, GBPUSD / Bitcoin / Gold / Silver tactically breaking out higher from recent trading ranges, the emerging market etf (EEM) breaking out higher…

  • …as are Caterpillar [CAT] + Deere & Co [DE]…

  • …with the Nikkei & ASX looking to break-out higher on previous resistance lvls…

  • Economics: Inflation themes wk with key figs out of US, CH + EZ. Also have GER ZEW & Aus jobs data.

  • Central Banks: Indonesia 4.0%e/p, South Koreas 0.50%e/p, Chile 0.50%e/p

    BOE’s Bailey set to speak on Tue 13 Oct 00:00 SGTRBA’s Lowe set to speak on Thu 15 Oct 05:45 SGT

  • Fed Speak: Quarles 3x, Clarida @ 21:00 (Wed 14 Oct), Kaplan 2x & Kashkari

  • Holidays: US & CA out on Mon (12 Oct)

-

Start-to-End = Gratitude + Integrity + Vision + Tenacity. Process > Outcome. Sizing > Idea.

This is the way 

KVP

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.